Publications by authors named "Glenn J Hanna"

41Publications

Rural patients with oral squamous cell carcinoma experience better prognosis and long-term survival.

Oral Oncol 2020 Oct 20;111:105037. Epub 2020 Oct 20.

Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2020.105037DOI Listing
October 2020

The diagnostic performance of CT and MRI for detecting extranodal extension in patients with head and neck squamous cell carcinoma: a systematic review and diagnostic meta-analysis.

Eur Radiol 2020 Sep 19. Epub 2020 Sep 19.

Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-020-07281-yDOI Listing
September 2020

Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI).

Br J Cancer 2020 Sep 1. Epub 2020 Sep 1.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-020-01044-8DOI Listing
September 2020

Impact of corticosteroids on allograft protection in renal transplant patients receiving anti-PD-1 immunotherapy.

Cancer Immunol Immunother 2020 09 25;69(9):1937-1941. Epub 2020 Jun 25.

Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-020-02644-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479641PMC
September 2020

Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.

Cancer 2020 Sep 18;126(17):3972-3981. Epub 2020 Jun 18.

Department of Hematology/Oncology, Memorial Sloan Kettering Cancer Center, New York City, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.33036DOI Listing
September 2020

Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma.

Oral Oncol 2020 07 11;106:104690. Epub 2020 Apr 11.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; BC Cancer, Vancouver Centre, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2020.104690DOI Listing
July 2020

Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck.

Oral Oncol 2020 06 3;105:104676. Epub 2020 Apr 3.

Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2020.104676DOI Listing
June 2020

ViroPanel: Hybrid Capture and Massively Parallel Sequencing for Simultaneous Detection and Profiling of Oncogenic Virus Infection and Tumor Genome.

J Mol Diagn 2020 04 15;22(4):476-487. Epub 2020 Feb 15.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2019.12.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193840PMC
April 2020

Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.

Cancer Epidemiol Biomarkers Prev 2019 10 29;28(10):1660-1667. Epub 2019 Jul 29.

Department of Radiation Oncology, Head and Neck Oncology Program, Dana-Farber Cancer Institute, Brigham and Women's Cancer Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-19-0038DOI Listing
October 2019

Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer.

Oral Oncol 2019 08 20;95:120-126. Epub 2019 Jun 20.

Robert and Renée Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2019.06.019DOI Listing
August 2019

Oral keratosis of unknown significance shares genomic overlap with oral dysplasia.

Oral Dis 2019 Oct 23;25(7):1707-1714. Epub 2019 Jul 23.

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/odi.13155DOI Listing
October 2019

Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma.

Oral Oncol 2018 10 17;85:29-34. Epub 2018 Aug 17.

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA 703-389-1895, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13688375183029
Publisher Site
http://dx.doi.org/10.1016/j.oraloncology.2018.08.005DOI Listing
October 2018

Human papillomavirus and oropharyngeal cancer.

Curr Probl Cancer 2018 09 27;42(5):466-475. Epub 2018 Jun 27.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01470272183010
Publisher Site
http://dx.doi.org/10.1016/j.currproblcancer.2018.06.005DOI Listing
September 2018

CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies.

Genes Chromosomes Cancer 2018 09 14;57(9):446-451. Epub 2018 Aug 14.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881821PMC
September 2018

Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Cancer Discov 2018 02 3;8(2):196-215. Epub 2017 Nov 3.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-17-0833DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809290PMC
February 2018

Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma.

Oral Oncol 2017 10 17;73:65-69. Epub 2017 Aug 17.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Division of Otolaryngology-Head & Neck Surgery, Brigham & Women's Hospital, 75 Francis Street, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2017.08.008DOI Listing
October 2017

Genomic analysis of metastatic cutaneous squamous cell carcinoma.

Clin Cancer Res 2015 Mar 14;21(6):1447-56. Epub 2015 Jan 14.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1773DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359951PMC
March 2015

Response and acquired resistance to everolimus in anaplastic thyroid cancer.

N Engl J Med 2014 Oct;371(15):1426-33

From the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School (N.W., E.M.V.A., N.G., R.I.H., D.J.K., P.A.J., L.A.G., J.H.L.), the Department of Medicine, Brigham and Women's Hospital and Harvard Medical School (N.W., E.M.V.A., Y.G., R.I.H., D.J.K., P.A.J., L.A.G., J.H.L.), the Departments of Pathology (J.A.B.) and Surgery (S.J.S., D.T.R.), Brigham and Women's Hospital, the Department of Medicine, Beth Israel Deaconess Medical Center (G.J.H.), and Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute (P.A.J.) - all in Boston; and Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard (N.W., E.M.V.A., A.A.-M., A.T.-W., M.R., G.G., D.J.K., S.L.C., D.M.S., L.A.G.), Whitehead Institute for Biomedical Research and the MIT Department of Biology (B.C.G., D.M.S.), and Howard Hughes Medical Institute, MIT (B.C.G., D.M.S.) - all in Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1403352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564868PMC
October 2014

Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future?

Oncologist 2013 26;18(3):288-93. Epub 2013 Feb 26.

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0286DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607525PMC
September 2013

Pathology quiz case 2. Solitary fibrous tumor (SFT) of the hypopharynx.

Arch Otolaryngol Head Neck Surg 2011 Aug;137(8):830; author reply 833-4

Georgetown University School of Medicine, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archoto.2011.127-aDOI Listing
August 2011